The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Impaired Irs–1/Pi3–Kinase Signaling in Patients With Hcv: A Mechanism for Increased Prevalence of Type 2 Diabetes
Open accessAbstract
Patients with hepatitis C virus (HCV) infection have a greater risk of developing type 2 diabetes mellitus. However, the mechanism of this association is unclear. In this study, we examined the potential defects in upstream insulin signaling pathways in liver specimens obtained from nonobese/nondiabetic subjects with HCV infection. Fasting liver biopsy specimens were obtained from 42 HCV–infected subjects and 10 non–HCV–infected subjects matched for age and body mass index. Liver tissues were exposed to insulin and examined for the contents and phosphorylation/activation status of the upstream insulin signaling molecules by immunoprecipitation and Western blot analysis. HCV infection resulted in a trend toward a 2–fold to 3–fold increase in insulin receptor (IR) and insulin receptor substrate (IRS)–1 contents when compared with non–HCV. In contrast, insulin–stimulated IRS–1 tyrosine phosphorylation was decreased by 2–fold in HCV–infected subjects compared with non–HCV–infected subjects (P < .05). The observed reductions in IRS–1 tyrosine phosphorylation were accompanied by a 3.4–fold decrease in IRS–1/p85 phosphatidylinositol 3–kinase (PI3–kinase) association and a 2.5–fold decrease in IRS–1–associated PI3–kinase enzymatic activity (P < .05 vs. non–HCV). This was accompanied by a marked reduction in insulin–stimulated Akt phosphorylation without any alterations in mitogen–activated protein kinase (MAPK) phosphorylation. Cellular contents of the hepatic p85 subunit of PI3–kinase were comparable between HCV–infected and non–HCV–infected subjects. In conclusion, we found that (1) HCV infection leads to a postreceptor defect in IRS–1 association with the IR and (2) insulin signaling defects in hepatic IRS–1 tyrosine phosphorylation and PI3–kinase association/activation may contribute to insulin resistance, which leads to the development of type 2 diabetes mellitus in patients with HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
White, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
IRS proteins and the common path to diabetes
White, M. F. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2001 · Cited by 925
SOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · STEM CELLS · doi:10.1634/stemcells.19-5-378 · Cited by 827
Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290235 · Cited by 659
Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells
White, M. F., Maron, R., & Kahn, C. R. (1985) · Nature · doi:10.1038/318183a0 · Cited by 651
Bastard, J.-P., Maachi, M., van Nhieu, J. T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J.-J., Capeau, J., & Hainque, B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8450 · Cited by 625
Allison, M. E. D., Wreghitt, T., Palmer, C. R., & Alexander, G. J. M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80631-2 · Cited by 454
Emanuelli, B., Peraldi, P., Filloux, C., Chavey, C., Freidinger, K., Hilton, D. J., Hotamisligil, G. S., & Van Obberghen, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104602200 · Cited by 449
Caronia, S., Taylor, K., Pagliaro, L., Carr, C., Palazzo, U., Petrik, J., O'Rahilly, S., Shore, S., Tom, B. D., & Alexander, G. J. M. (1999) · Hepatology · doi:10.1002/hep.510300416 · Cited by 396
Lavan, B. E., Fantin, V. R., Chang, E. T., Lane, W. S., Keller, S. R., & Lienhard, G. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21403 · Cited by 380
Lavan, B. E., Lane, W. S., & Lienhard, G. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11439 · Cited by 349
Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus Infection
Knobler, H., Schihmanter, R., Zifroni, A., Fenakel, G., & Schattner, A. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.355 · Cited by 292
Ueki, K., Fruman, D. A., Brachmann, S. M., Tseng, Y.-H., Cantley, L. C., & Kahn, C. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.965-977.2002 · Cited by 285
Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor
Mooney, R. A., Senn, J., Cameron, S., Inamdar, N., Boivin, L. M., Shang, Y., & Furlanetto, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010579200 · Cited by 282
High Prevalence of Hepatitis C Virus Infection in Diabetic Patients
Simó, R., Hernández, C., Genescà, J., Jardí, R., & Mesa, J. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.998 · Cited by 275
Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C
Petit, J.-M., Bour, J.-B., Galland-Jos, C., Minello, A., Verges, B., Guiguet, M., Brun, J.-M., & Hillon, P. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00143-x · Cited by 273
Kadowaki, T., Koyasu, S., Nishida, E., Tobe, K., Izumi, T., Takaku, F., Sakai, H., Yahara, I., & Kasuga, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48242-7 · Cited by 191
Naka, T., Tsutsui, H., Fujimoto, M., Kawazoe, Y., Kohzaki, H., Morita, Y., Nakagawa, Narazaki, M., Adachi, K., Yoshimoto, T., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00132-7 · Cited by 186
Dominici, F., Hauck, S., Argentino, D., Bartke, A., & Turyn, D. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730081 · Cited by 176
Sun, Y., Liu, S., Ferguson, S., Wang, L., Klepcyk, P., Yun, J. S., & Friedman, J. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200964200 · Cited by 174
Krebs, D. L., Uren, R. T., Metcalf, D., Rakar, S., Zhang, J., Starr, R., Souza, D. P. D., Hanzinikolas, K., Eyles, J. L., Connolly, L., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4567-4578.2002 · Cited by 163
Buren, J., Liu, H., Jensen, J., & Eriksson, J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460419 · Cited by 159
Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection.
FRASER, G. M., Harman, I., Meller, N., Niv, Y., & Porath, A. (1996) · PubMed · Cited by 142
Matsumoto, M., Ogawa, W., Teshigawara, K., Inoue, H., Miyake, K., Sakaue, H., & Kasuga, M. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1672 · Cited by 140
HCV and diabetes mellitus: evidence for a negative association
Mangia, A., Schiavone, G., Lezzi, G., Marmo, R., Bruno, F., Villani, M. R., Cascavilla, I., Fantasia, L., & Andriulli, A. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00688.x · Cited by 131
Gray, H., Wreghitt, T. G., STRATTON, I. M., Alexander, G., Turner, R. C., & O’Rahilly, S. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00466.x · Cited by 129
Shemer, J., Adamo, M. L., Wilson, G. L., Heffez, D., Zick, Y., & LeRoith, D. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47751-4 · Cited by 118
Qiao, L.-Y., Zhande, R., Jetton, T. L., Zhou, G., & Sun, X. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201494200 · Cited by 104
Begum, N., Ragolia, L., Rienzie, J., McCarthy, M., & Duddy, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25164 · Cited by 91
Self-citationElevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus
Malaguarnera, M., Fazio, I. D., Romeo, M. A., Restuccia, S., Laurino, A., & Trovato, B. A. (1997) · Journal of Gastroenterology · doi:10.1007/bf02936370 · Cited by 91
Sandu, O. A., Ragolia, L., & Begum, N. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2178 · Cited by 84
Self-citationHigh prevalence of diabetes mellitus among adult β-thalassaemic patients with chronic hepatitis C
Labropoulou‐Karatza, C., Goritsas, C. P., Fragopanagou, H., Repandi, M., Matsouka, P., & Alexandrides, T. K. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199909000-00014 · Cited by 55
Sandu, O. A., Ito, M., & Begum, N. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1475 · Cited by 54
Self-citationAssociation between Hepatitis C Virus Infection and Diabetes Mellitus
Mehta, S. H., Strathdee, S. A., & Thomas, D. L. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000808 · Cited by 49
Zhang, B. B. (2002) · Frontiers in bioscience · doi:10.2741/a820 · Cited by 48
Kaburagi, Y., Yamauchi, T., Yamamoto‐Honda, R., Ueki, K., Tobe, K., Akanuma, Y., Yazaki, Y., & Kadowaki, T. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.suppl_s25 · Cited by 47
Jiang, G. (2002) · Frontiers in bioscience · doi:10.2741/jiang · Cited by 41
Sougleri, M., Labropoulou-Karatza, C., Paraskevopoulou, P., Fragopanagou, H., & Alexandrides, T. K. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200110000-00012 · Cited by 30
Öncül, O., Top, C., & Çavuþlu, Þ. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.937 · Cited by 15
Hiperinsulinemia en pacientes cirróticos infectados por el virus de la hepatitis C
Serrano, A. G., Igea, F., Lepe, J. A., Gil, S. P., & Reina, A. G. (2001) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(01)70138-0 · Cited by 13
Fukui, M., Kitagawa, Y., Nakamura, N., & Yoshikawa, T. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1900 · Cited by 6
Öncül, O., Top, C., & Çavuşlu, Ş. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1901 · Cited by 1
Cited by
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
Moucari, R., Asselah, T., Cazals–Hatem, D., Voitot, H., Boyer, N., Ripault, M., Sobesky, R., Martinot–Peignoux, M., Maylin, S., Nicolas–Chanoine, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.010 · Cited by 546
Kawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., Ide, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63408-6 · Cited by 536
STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?
Asselah, T., Rubbia-Brandt, L., Marcellin, P., & Negro, F. (2006) · Gut · doi:10.1136/gut.2005.069757 · Cited by 395
Metadata
- Authors
- Aytug, S., Reich, D., Sapiro, L. E., Bernstein, D., & Begum, N.
- Venue
- Hepatology
- Published
- 2003-12
- Volume
- 38
- Issue
- 6
- Pages
- 1384-1392
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2081454569
- Cited by
- 340
- References
- 48
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.